Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.390
+0.160 (3.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Rezolute Market Cap
Rezolute has a market cap or net worth of $254.37 million as of December 20, 2024. Its market cap has increased by 596.90% in one year.
Market Cap
254.37M
Enterprise Value
138.63M
1-Year Change
596.90%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $254.37M, an increase of 52.32%. That is a compound annual growth rate of 10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 254.40M | 547.33% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chimerix | 256.32M |
| Larimar Therapeutics | 253.95M |
| Eledon Pharmaceuticals | 252.10M |
| Cidara Therapeutics | 246.23M |
| Renovaro | 245.22M |
| Abeona Therapeutics | 244.74M |
| Artiva Biotherapeutics | 242.89M |
| Anika Therapeutics | 239.16M |